S14
AFRICA
CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015
outcomes in the elderly.
Kidney Int
2003;
63
(3): 1121–1129.
7.
Keith DS, Nicholas GA, Gullion CM, Brown JB, Smith DH.
Longitudinal follow up and outcomes among a population with chronic
kidney disease in a large managed care organization.
Arch Intern Med
2004;
164
(6): 659–663.
8.
Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska
KA. The mechanism of phosphorus as a cardiovascular risk factor in
CKD.
J Am Soc Nephrol
2008;
19
: 1092–1105.
9.
Mann JF,
Gerstein HC,
Yi QL, Lonn EM,
Hoogwerf BJ,
Rashkow A,et al.
Development of renal disease in people at high cardiovascular
risk: Results of the HOPE randomized study.
J Am Soc Nephrol
2003;
14
: 641–647.
10. Menon V, Sarnak MJ. The epidemiology of chronic kidney disease
stages 1 to 4 and cardiovascular disease: A high risk combination.
Am J
Kidney Dis
2005;
45
: 223–232.
11. Satko SG, Sedor JR, Iyengar SK, Freedman BI. Familial clustering of
chronic kidney disease.
Semin Dial
2007;
20
(3): 229–236.
12. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal
disease.
Kidney Int Suppl
2005;
94
: S46–49.
13.
Inssera FDG,
Alpino AMS. Relatives of dialysis patients with increased
risk of renal failure.
Medicina
(Beunos Aires) 2007;
67
(1): 8–18.
14. Tsai JC, Chen SC, Hwang SJ, Chang JM, Lin MY, Chen HC. Prevalence
and risk factors for CKD in spouses and relatives of haemodialysis
patients.
Am J Kidney Dis
2010;
55
(3): 78–104.
15.
Wei X, Li Z,
Chen W,
Mao H, Li Z,
Dong X,
et al.
Prevalence and risk
factors of chronic kidney disease in first-degree relatives of chronic
kidney disease patients in southern, China.
Nephrol Carlton2012;
17
(2):
123–130.
16. Salkeld G, Phongsavan P, Oldenburg B, Johannesson M, Convery P,
Graham Clarke P,
et al
. The cost-effectiveness of a cardiovascular
risk reduction program in general practice. Health policy (New York).
Ireland: Elsevier Sci Ltd, 1997;
41
(2): 105–119.
17. Brunner E, Cohen D, Toon L. Cost effectiveness of cardiovascular
disease prevention strategies: a perspective on EU food based dietary
guidelines.
Public Health Nutr
2001;
4
(2B): 711–715.
18. Chamnan P, Simmons RK, Khaw K-T, Wareham NJ, Griffin SJ.
Estimating the population impact of screening strategies for identifying
and treating people at high risk of cardiovascular disease: modelling
study.
Br Med J
2010;
340
: c1693.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D.
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.Ann Intern Med 1999;
130
(6): 461–470.
http://www.qxmd.com/calculate-online/nephrology/mdrd-egfr. Accessed September 24, 2014.
20. WHO guideline on prevention, detection and treatment of diabetes
mellitus, 2007.
http://www.who.int/diabetes/publications/en/. Accessed
September 12, 2014.
21. WHO/ISH Hypertension guidelines, 2005.
http://www.who.int/cardio- vascular_diseases/guidelines/hypertension/en/.Accessed September 12,
2014.
22. WHO | Obesity and overweight [Internet]. World Health Organisation
Media Centre fact sheet No. 311. 2012.
http://www.who.int/mediacentre/ factsheets/fs311/en. Accessed October 18, 2014.
23. Waist circumference and waist–hip ratio. Report of a WHO expert
consultation, 2008.
http://www.who.int/nutrition/publications/obesity/ WHO_report_waistcircumference_and_waisthip_ratio/en/. Accessed
October 18, 2014.
24. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen, W, Paccaud F,
et al
. Prevalence of hyperuricemia and relation of serum uric acid with
cardiovascular risk factors in a developing country.
BMC public Health
2004;
34
: 1473–1482.
25. Executive summary of the Third Report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III). Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults.
J Am Med Assoc
2001;
285
(19):
2486–2497.
26.
Morse RM, Flavin DK. The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism. J Am Med Assoc 1992; 268 : 1012.27. Husten CG. How should we define light or intermittent smoking? Does
it matter?
Nicotine Tob Res
2009;
11
: 111–121.
28. Oyegbade OO, Abioye-Kuteyi EA, Kolawole BA, Ezeoma IT, Bello IS.
Screening for Diabetes mellitus in a Nigerian family practice population.
SA Fam Pract
2007;
49
(8): 15–21.
29. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi OJ, Onwubere BJC,
Falase AO,
et al.
Blood pressure, prevalence of hypertension and hyper-
tension related complications in Nigerian Africans: A review.
World J
Cardiol
2012;
4
(12): 327–340.
30. Mvo Z, Dick J, Steyn K. Perceptions of overweight African women
about acceptable body size of women and children.
Curationis
1999;
22
(2): 27–31.